Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells
- Christian Meyer zum Büschenfelde
- , Christine Hermann
- , Burkhard Schmidt
- , Christian Peschel
- , Helga Bernhard
- Technical University of Munich
Research output: Contribution to journal › Article › peer-review
117
Scopus
citations